Form 4 holding
Interim CFO
TNF Pharmaceuticals, Inc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 25,000
- Estimated value
- Report date
- 17 Apr 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount